Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (1): 189-193    DOI: 10.31083/j.ceog.2021.01.2176
Case Report Previous articles | Next articles
Disseminated intravascular coagulation developed after suction curettage in an adenomyosis patient: a case report and literature review
Xiao-Cen Niu1, Li-Hua Zhu1, Zhi-Da Qian1, Li-Li Huang1, *()
1Women's hospital, School of Medicine, Zhejiang University, Hangzhou, 310006 Zhejiang Province, P. R. China
Download:  PDF(305KB)  ( 114 ) Full text   ( 16 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Disseminated intravascular coagulation (DIC) is a high mortality coagulopathy. The basic diseases that can induce DIC include: obstetric events, metastatic malignancy, massive trauma and bacterial sepsis. But in this article, we reported on an extremely rare case of DIC in an adenomyosis patient who had undergone suction curettage on account of unwanted pregnancy. The patient had been successfully treated with transfusion of fresh frozen plasma and subcutaneous injection of nadroparin calcium instead of hysterectomy. A decrease in progesterone, bleeding in the adenomyosis lesions, tissue necrosis, releasing of tissue factors, activating of the exogenous coagulation system might play the crucial roles in the pathophysiology of acute DIC. Since early detection and treatment are essential for the prognosis of DIC. It is suggested to strengthen the monitoring of coagulation function in such patients.
Key words:  DIC      Early pregnancy      Suction curettage      Adenomyosis     
Submitted:  03 June 2020      Revised:  19 August 2020      Accepted:  20 August 2020      Published:  15 February 2021     
*Corresponding Author(s):  Li-Li Huang     E-mail:  fbjys@zju.edu.cn

Cite this article: 

Xiao-Cen Niu, Li-Hua Zhu, Zhi-Da Qian, Li-Li Huang. Disseminated intravascular coagulation developed after suction curettage in an adenomyosis patient: a case report and literature review. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 189-193.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.01.2176     OR     https://ceog.imrpress.com/EN/Y2021/V48/I1/189

[1] Ja Young Kim, Yun Gyu Song, Chang-Woon Kim, Moon Ok Lee. Uterine artery embolization using gelatin sponge particles for symptomatic focal and diffuse adenomyosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 59-65.
[2] Wu Shun Felix Wong, Xiao-Gang Zhu, Min Xue. Adenomyosis – Is a new treatment solution available?[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 5-8.
[3] Dubravko Habek, Matija Prka, Anto Čartolovni, Anis Cerovac, Domagoj Dokozić. Caesarean section between doctrine to heresis. Medicoethical and deontological view of caesarology: an opinion[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 1-4.
[4] Yan-Bing Xiao, Meng Mou, Heng-Fang Gu, Hui-Xing Li, Meng-Yuan You, Zhi-Gang Liang, Lei Han. The impact of major uterine wall resection and reconstruction of the uterus (MURU) on uterine hemodynamics and ovarian function in patients with adenomyosis: a clinical study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 132-137.
[5] J. Jin, J. Tang. Clinical application and economics of five short-acting combined oral contraceptives over five years of obstetrics and gynecology practice in China based on real-world study[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 940-949.
[6] S.Y. Song, G.W. Lee, J.B. Yang, D.E. Kim, D.B. Park, H.J. Yoo. Septic shock caused by abscess formation inside cystic adenomyosis after responsive treatment of pelvic inflammatory disease[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 983-987.
[7] H. Takagi, S. Yamada, J. Sakamoto, S. Fujita, T. Sasagawa. Hemostatic effects of kyukikyogaito in dienogest treatment[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 560-564.
[8] J. Ogawa, S. Suzuki. Risk factors of self-interruption of medications for mental disorders in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 576-578.
[9] H.S. Song, Y.A. Kim. Placenta percreta at 33 weeks of gestation after laparoscopic radiofrequency ablation for adenomyosis and Conservative Surgical Treatment: A case report and review of literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 600-603.
[10] Xiao-Tao Huang, Shao-Rong Liang, Lu Wang. Acupuncture combined with Chinese and western medicine in the treatment of polycystic ovary syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 396-400.
[11] A.P. Londero, S. Visentin, L. Marin, M. C. Bongiorno, D. Visentin, S. Bertozzi, E. Cosmi, A Cagnacci, L. Driul. Second trimester prediction of small for gestational age and intrauterine growth restriction[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 70-74.
[12] Y. Wu, L. Tong, L. Xiao. Artificial neural network models for prediction of premature ovarian failure[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 958-963.
[13] S. Nayak, A. Avery, J. McLeod Griffiss, C.D. Charles, K.R. Culwell. A randomized placebo-controlled pilot study of the effect and duration of Amphora, a multipurpose vaginal pH regulator, on vaginal pH[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 736-742.
[14] H.H. Wang, L.P. Zhu, J.J. Zhang, B. Han, Y. Wang. Predicting adverse outcomes of hypertensive disorders in pregnancy: validation of fullPIERS model in Chinese population[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 743-747.
[15] A. Pontis, L. Nappi, F. Sorrentino, S. Angioni. Differential diagnosis of adenomyosis: the role of hysteroscopy and laparoscopy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 511-515.
No Suggested Reading articles found!